Chinese Insurers Invest Over $250M in Hong Kong IPOs Amid Policy Support

Gate News message, April 22 — Mainland Chinese insurers have invested more than US$250 million in Hong Kong IPOs this year, according to UBS. Ping An, Taikang Life, New China Life, and China Post Life account for most of the activity, which already nears last year's total.

The investments have mainly flowed into AI, semiconductor, new energy, and biotechnology stocks. Low interest rates at home and Beijing's backing for long-term equity investment have driven insurers toward higher-return listings. Regulatory changes, including reduced risk weights on certain stock holdings and lower capital charges for long-term positions, have encouraged insurers to act as "patient capital" in the market.

The shift reflects broader government efforts to deploy China's insurance industry funds—which totaled 38.5 trillion yuan (US$5.65 trillion) by end-2025—toward emerging and future industries. Large cornerstone commitments from insurers also boost investor confidence in Hong Kong IPOs, particularly as the city has become the preferred listing venue for mainland Chinese companies amid valuation limits in the A-share market.